Bovine Diagnostics Market is expected to reach US$ 2,011.15 million by 2030

High Prevalence of Bovine Tuberculosis Likely to Offer Opportunities to Bovine Diagnostics Market

According to our new research study on "Bovine Diagnostics Market Forecast to 2030 – COVID-19 Impact and Global Analysis – by Product, Disease Type, and End User," the market was valued at US$ 1,155.59 million in 2022 and is expected to reach US$ 2,011.15 million by 2030. It is estimated to register a CAGR of 7.2% during 2022–2030.

Bovine tuberculosis (bTB) is a chronic infectious disease that primarily affects cattle, and is later transmitted to other animals and humans. The World Organization for Animal Health (WOAH) has listed bTB as one of the diseases that must be detected and reported as earliest as possible. As per the data shared by Thermo Fisher Scientific in May 2023, bTB affects more than 50 million cattle worldwide, incurring annual economic losses of ~US$ 3 billion. In the UK, the disease incurs financial losses of ~US$ 145 million each year. The prevalence of bTB differs in different geographic areas. It is rare in Europe, Canada, and the US; however, its prevalence reaches beyond bTB 50% in Africa and some parts of Asia. Despite the ongoing technological and infrastructural developments, many countries fail to effectively diagnose bTB due to the complexity of the disease, which results in the lack of universal strategies for its diagnosis. This scenario provides opportunities for bovine diagnostics market players to enhance awareness in Africa and Asia, and launch new products that suit the socioeconomic conditions in these countries.

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00030034

Companies in the bovine diagnostics market are developing different techniques and showcasing those in formal events such as seminars. In March 2023, the STAR-IDAZ International Research Consortium (IRC), Birmingham, UK, showcased the Future of bTB research under the microscope in a workshop organized online by a group of organizations. The consortium includes the WOAH, the UK Department for Environment, Food & Rural Affairs (DEFRA), UK Research and Innovation (UKRI), and Kreavet. This global virtual event was attended by ~100 experts from Europe, Africa, Asia, the US, and South America. The IRC aims to coordinate research at the international level, contributing to new and improved animal health strategies. Also, the event concluded that global benefits would be provided through future research context-appropriate solutions.

The report segments the Bovine Diagnostics Market as follows:

The bovine diagnostics market, by product, is segmented into immunoassay kits, PCR kits, hemagglutination inhibition (HI) assay, and others. The immunoassay kits segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022–2030.

Based on disease type, the bovine diagnostics market is categorized into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and others. The bovine mastitis segment held the largest market share in 2022 and is also anticipated to register the highest CAGR during 2022–2030.

On the basis of end user, the bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022–2030. 

Region Analysis – Bovine Diagnostics Market

In terms of geography, the global bovine diagnostics market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America holds the largest market share, while Asia Pacific is expected to register the fastest CAGR during 2022–2030. In Asia Pacific, China is the largest market for bovine diagnostics. According to an article published in BMC Journals in 2023, bTB is a major endemic in China that results in major losses in dairy cattle production. The Ministry of Agriculture and Rural Affairs in China has classified the bTB as one of the 16 infectious diseases in dairy cattle that should be controlled and eliminated, as the disease also affects human welfare in addition to the livestock industry. The ministry plans to eliminate bTB in its Medium and Long-Term National Plan during 2012–2020 for the Prevention and Control of Animal Diseases. A milk-based test is performed for bovine brucellosis, Mycoplasma bovis (M. bovis) disease, paratuberculosis, and bovine leukosis, among others. The collection and testing of milk samples do not have much impact on dairy cows, which also results in greater cooperation from dairy workers. The National Dairy Herd Improvement (DHI) Program of China also emphasizes on the collection of milk samples from lactating cows monthly, followed by testing them to assess breeding suitability and milk quality. It also recommends evaluating the milk samples to detect mastitis in the early stages using a CombiFoss FT + milk composition and a somatic cell analyzer. China implements its current bTB control strategy through test-and-slaughter policies, which are based on surveillance programs at the national and local levels, as well as on farms. Mycobacterium bovis culture is the “gold standard” for diagnosing bTB. However, the identification of M. bovis by culturing it is insensitive, cumbersome, and time-consuming, and it requires high-level biosafety laboratory facilities because of the persistent infection, slow growth, and potentially dangerous characteristics of the pathogen. Currently, the tuberculin skin test is the recommended and conventional test performed on animals at farms in China for detecting bTB, while the blood interferon-gamma in vitro release test is an alternative laboratory diagnostic test available. Thus, increasing bTB disease incidence and support by the government to encourage large-scale diagnosis boost the growth of the bovine diagnostics market in China.

Idexx Laboratories Inc, PBD Biotech Ltd, Thermo Fisher Scientific Inc, Innovative Diagnostics SAS, Neogen Corp, Enfer Labs, bioMerieux SA, Ring Biotechnology Co Ltd, Bionote Inc, and Shenzhen Bioeasy Biotechnology Co Ltd are among the leading companies operating in the bovine diagnostics market.

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com